Compare CRWS & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWS | KYNB |
|---|---|---|
| Founded | 1957 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4M | 32.8M |
| IPO Year | 1994 | 2014 |
| Metric | CRWS | KYNB |
|---|---|---|
| Price | $2.36 | $5.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.50 |
| AVG Volume (30 Days) | ★ 56.5K | 22.5K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | ★ 5.04% | N/A |
| EPS Growth | 118.89 | ★ 9552.08 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $70,270,000.00 | $6,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.12 |
| P/E Ratio | $13.88 | ★ N/A |
| Revenue Growth | ★ 6.51 | N/A |
| 52 Week Low | $2.30 | $4.85 |
| 52 Week High | $3.14 | $9.66 |
| Indicator | CRWS | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 37.97 | 29.52 |
| Support Level | N/A | N/A |
| Resistance Level | $2.58 | $7.41 |
| Average True Range (ATR) | 0.07 | 0.37 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 22.59 | 17.37 |
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.